Sam North

Content and SEO lead

Sam combines more than a decade of hands-on cannabis cultivation experience with six years working across content, SEO, and digital strategy.

After moving from cultivation into cannabis writing in 2020, his role developed beyond editorial content to encompass SEO, content strategy, and search-led digital growth. His experience now spans editorial and educational content, search-led website strategy, and the use of performance data to guide how content is structured, developed, and improved. Central to his work is a passion for cannabis education, helping to destigmatise cannabis through clear, accurate, and accessible information.

Since 2023, Sam has focused predominantly on the UK medical cannabis sector. At Glass Pharms®, he leads content and SEO, helping shape the company’s website and organic search strategy while communicating the science, technology and expertise behind its approach to pharmaceutical cannabis cultivation.

Articles by

Supply Agreement with Integro/IPS

By Glass Pharms | 15/12/2025

Glass Pharms® has announced a supply agreement with Integro Clinic and IPS Pharmacy to provide them with a new premium range of Glass Pharms branded CBPMs made with domestically grown flower from the Glass Pharms facility. These will be available from IPS Pharmacy for patients at Integro and Medicann clinics, as well as for patients at other UK clinics.

More Police Education Needed

By Glass Pharms | 18/11/2025

Policing Journal An interesting and candid research paper in the Policing Journal reveals the current state of policing medical cannabis in the UK. Awareness remains poor with knock-on impacts to patients and the police’s ability to do their job collaboratively. We have been engaged with police education with four police forces and another two lined up. It was nice to see this work, which we have been doing in collaboration with Releaf Clinic, referenced in the paper. Policing: A Journal of Policy and Practice, Volume 19, 2025, paaf047,

LBC visit Glass Pharms

By Glass Pharms | 07/11/2025

LBC Visit Glass Pharms LBC, our CEO's favourite radio station, visited the Glass Pharms site to learn more about the state of the UK Medical Cannabis industry in partnership with Mamedica clinic. LBC Reporter Fraser Knight was fascinated by the tour and interviewed Jon Robson, CEO of Mamedica and James Duckenfield, CEO of Glass Pharms in August this year and broadcast the piece in the last 25 minutes of Shelagh Fogarty's Show on 7th November. Snoop Dog has not invested in Glass Pharms but has invested in Mamedica clinic through Casa Verde Capital as the UK marketplace continues to see...

Glass Pharms Reaches 1000th Batch Milestone

By Glass Pharms | 13/10/2025

Glass Pharms Reaches 1000th Batch MilestoneGlass Pharms is proud to announce the planting of our 1000th batch of medical cannabis, a significant milestone in our ongoing mission to cultivate excellence and improve patient outcomes.This achievement reflects the hard work, precision, and dedication of our entire team, who consistently uphold the highest standards of compliance, safety, and quality at every stage of production. From cultivation through to quality assurance, every member of the Glass Pharms team plays a vital role in producing clean, safe, and consistent medical cannabis for patients who rely on it.Through our trusted partner clinics and pharmacies across...

Avon & Somerset Police Education Day

By Glass Pharms | 08/10/2025

Avon & Somerset Police Education Day 08/10/25 We were delighted to welcome the drug expert team from the Avon & Somerset Police force on Wednesday 8th October 2025 for an education day onsite at Glass Pharms in collaboration with Releaf Clinic. This was part of our ongoing process of mutual education and collaboration with law enforcement.

Supply Agreement with CB1 & Launch of EcoCann

By Glass Pharms | 07/08/2025

Glass Pharms Agree Supply Arrangement with CB1 Clinic After a successful period of patient feedback, prescribing Cannabis-Based Product for Medicinal Use in humans (CBPM) derived from Glass Pharms’, UK grown, medical cannabis flower, CB1 Pharmacy have agreed a supply agreement via Xeal Pharma.

« Previous
1
2
3
4
5
…
8
Next »